Clinical Trial Details
Back to clinical trials
Phase N/AAncillary or Correlative
EU5011-20: Development of a Minimally Invasive Radio-Genomics Biomarker for Early Detection of Pancreatic Cancer
Protocol: STUDY00000513
Overview
Primary Objective:
-
To validate the performance of the minimally invasive multi-dimensional biomarker panel for early PDAC diagnosis in prospective cohorts of PDAC
-
To combine the powers of imaging and genomics using artificial intelligence to improve the accuracy PDAC Diagnosis
Investigators
Location
Winship Cancer Institute